USA Financial Formulas’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,235
Closed -$377K 348
2023
Q3
$377K Buy
1,235
+1,234
+123,400% +$426K 0.56% 48
2023
Q2
$354 Hold
1
﹤0.01% 461
2023
Q1
$334 Buy
+1
New +$295 ﹤0.01% 400
2022
Q3
$0 Hold
1
﹤0.01% 295
2022
Q2
$0 Hold
1
﹤0.01% 324
2022
Q1
$0 Hold
1
﹤0.01% 349
2021
Q4
$1K Sell
1
-1,727
-100% -$1.11M ﹤0.01% 289
2021
Q3
$1.15M Sell
1,728
-22
-1% -$14.9K 1.03% 21
2021
Q2
$1.07M Sell
1,750
-2,330
-57% -$1.38M 0.9% 46
2021
Q1
$2.21M Buy
4,080
+101
+3% +$55.8K 1.79% 4
2020
Q4
$2.13M Buy
+3,979
New +$1.79M 1.68% 14
2019
Q1
Sell
-19,224
Closed -$7.52M 126
2018
Q4
$7.52M Buy
19,224
+17,896
+1,348% +$4.52M 1.87% 18
2018
Q3
$454K Buy
+1,328
New +$490K 0.12% 132
2018
Q1
Sell
-18,479
Closed -$4.11M 308
2017
Q4
$4.11M Sell
18,479
-3,844
-17% -$873K 0.98% 27
2017
Q3
$4.16M Buy
+22,323
New +$3.82M 0.99% 24
2016
Q4
Sell
-8,808
Closed -$826K 244
2016
Q3
$826K Sell
8,808
-1,231
-12% -$111K 0.21% 101
2016
Q2
$809K Buy
+10,039
New +$768K 0.22% 96

Other funds holding ALGN

USA Financial Formulas's ALGN Position: Q4 2023 in Review

USA Financial Formulas sold out of Align Technology (ALGN) in Q4 2023, closing a stake of 1,235 shares — an estimated $377K sold.

USA Financial Formulas first reported a position in ALGN in Q2 2016 and held it in 17 quarters. The position peaked at $7.52M in Q4 2018. 789 funds tracked by Wall St. Rank hold ALGN as of Q4 2023.

  • USA Financial Formulas reported no remaining Align Technology position as of Q4 2023 after selling out during the quarter.
  • USA Financial Formulas sold 1,235 Align Technology shares in Q4 2023, an estimated $377K.
  • USA Financial Formulas first reported a position in Align Technology in Q2 2016 and held it in 17 quarters.
  • USA Financial Formulas's Align Technology position peaked at $7.52M in Q4 2018.
  • 789 funds tracked by Wall St. Rank held Align Technology as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.